Home
IMPACT PH Lecture Series
Education
PAH TV Clinical Insights
PAH.tv Network
Slidesets and Resources
You are here :
PAH.tv Network
Login
|
Register
Please select a video from the list below.
What is Tolerance to Therapy on PDE-5 or PGI-2?
Is drug tolerance a real thing? It is difficult to assess if PAH is progressing, or if a drug is less effective because of changes in the patient's body over time. In this program, Dr. Jim White discusses the concept of tolerance, and how this may affect treatment choices. To earn up to 1.25 FREE credit hours for viewing this and other programs in this series, click the link below.
FREE CE Credit Available: Approach to the PAH Patient on Monotherapy and Not at Goal
Recent Video
|
Most Viewed
Specialties :
<All Specialties>
Allied Health
Clinical Insights
Clinical Trials
Lecturer Bios
News
PAH
Search :
When to Add or Switch Therapy
Views - 61
RESPITE: Evidence to Support a Switch Approach?
Views - 283
Switching from PDE-5 to sGC Stimulator
Views - 49
What is Tolerance to Therapy on PDE-5 or PGI-2?
Views - 165
What are the Choices When Escalating Therapy?
Views - 618
Parameters for Treatment Success
Views - 32
When Should Patients be Evaluated for Efficacy?
Views - 192
General Goals of Therapy for Patient on Monotherapy
Views - 55
Early Combination Therapy: Applying Aggressive Goals
Views - 33
Preventing Hospitalization in PAH Through Aggressive Early Therapy
Views - 67
Future Directions in PAH Therapy and Clinical Research
Views - 306
Quality of Life Issues in the Treatment of PAH
Views - 36
What Are the Risks to Combination Therapy?
Views - 56
Neurohormone in the Pathobiology of PH: Beta-blockers
Views - 43
Palliative Care in Pulmonary Arterial Hypertension
Views - 85
Oral Prostanoids for the Mgmt of PH: The Holy Grail or Beraprost Revisited?
Views - 158
Neurohormone in the pathobiology of PH: RAAS
Views - 30
Case Presentation: Palliative Care in PAH
Views - 14
Mitral Valve Disease and the Development of Pulmonary Arteriopathy
Views - 105
Vascular and Endothelial Biomarkers in PAH
Views - 30
Case of Atrial Septal Defect Associated with PH
Views - 1619
WHO Group II PH Due to Heart Failure w/Preserved Ejection Fraction
Views - 602
Case of a 58 Year Old with Scleroderma
Views - 352
Understanding the Diagnosis and Treatment of PAH
Views - 200
20 Years of Prostanoids: Spanning the Continuum of Care in PAH
Views - 554
Group 1 and Beyond: Case Studies in PH
Views - 135
Insights from Fetal Imaging
Views - 87
Pathophysiology of PH in the ICU
Views - 91
ICU Management of PH
Views - 111
Animal Models of PH
Views - 55
Novel Endothelial Targets
Views - 43
Treatment of Angioproliferative PAH
Views - 35
Right Ventricular Targets
Views - 68
Fontan Circulation Response to Exercise
Views - 47
Aberrations of the Pulmonary Vasculature in the Fontan Circulation
Views - 32
Pulmonary Vasodilatation in the Fontan Circulation
Views - 55
Outcomes after The Fontan Operation
Views - 355
Combination Therapy Strategies
Views - 114
Following Patients with Congenital Diaphragmatic Hernia (CDH)
Views - 226
Prostanoids in Pediatric PAH
Views - 80
Impact of PAH Targeted Therapy on Pediatric Outcome
Views - 359
The phaware365 Mobile App
Views - 61
Yoga in the Treatment of Pulmonary Hypertension
Views - 46
SC TreprostinilTherapy: Managing Site Pain
Views - 32
RV Dysfunction/Failure: Pathophysiology and Classification
Views - 41
The NO-cGM Pathway in PAH
Views - 135
CTEPH: State of the Art
Views - 146
Holding Court in PAH
Views - 1560
Following Patients with PAH
Views - 2664
Newer Studies in Combination Therapy
Views - 403
Guidelines for the Treatment of PAH
Views - 967
Oral Prostacyclins in the Treatment of PAH
Views - 936
Key Steps in Performing PTE Surgery
Views - 140
CTEPH Basics
Views - 65
Reassessing a Misdiagnosis
Views - 56
V/Q Scanning and RHC in CTEPH
Views - 48
IPF, Distinguishing Among Fibrotic Lung Conditions
Views - 239
Diagnosis IPF, Focus on Environmental Exposure
Views - 76
Diagnosis of IPF, Focus on Radiology and Pulmonology
Views - 51
Diagnosis of IPF, Focus on Decision to Obtain Biopsy
Views - 49
PAH: A Customized Approach to Treatment
Views - 86
DVT: Controversies in Pulmonary Embolism
Views - 170
Interpreting Waveforms in Patients with PH
Views - 68
Cases in PAH: Sarcoidosis
Views - 329
Challenges of Interpreting Testing
Views - 296
New Insights: Surgical Intervention in CTEPH
Views - 347
PAH In the High Risk Patient
Views - 120
The INFORM Study
Views - 395
GRIPHON: Dose related efficacy with oral selexipag
Views - 516
Referring PAH Patients for Lung Transplant
Views - 113
New Approaches to Drug Therapy in PAH
Views - 214
Non Pharmacologic Management of PAH
Views - 215
Mental Health in PAH
Views - 301
US Research Day, Welcome from Dr. Vallerie McLaughlin
Views - 190
US Research Day, Update on Recent Clinical Trial Results
Views - 451
Privacy
|
Terms Of Use
|
Contact Us
|
Copyright 2017 by PAH.tv
|
About PAH.tv